Published in Investig Clin Urol on May 10, 2016
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med (2004) 32.09
Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med (2012) 20.79
Molecular determinants of resistance to antiandrogen therapy. Nat Med (2003) 18.90
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol (2008) 18.54
Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore (1994) 16.38
Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science (2009) 13.87
The development of androgen-independent prostate cancer. Nat Rev Cancer (2001) 11.88
Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med (2014) 11.05
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res (2008) 10.66
Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol (2005) 10.48
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol (2008) 7.89
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat (2015) 6.31
Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer. Clin Cancer Res (2009) 3.61
Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res (2006) 3.12
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol (2008) 1.93
Drug resistance in metastatic castration-resistant prostate cancer. Nat Rev Clin Oncol (2010) 1.86
Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol (1995) 1.82
Characterising the castration-resistant prostate cancer population: a systematic review. Int J Clin Pract (2011) 1.75
Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial. Eur Urol (2014) 1.47
Prostate cancer in Asian men. Nat Rev Urol (2014) 1.46
The change of prostate cancer treatment in Korea: 5 year analysis of a single institution. Yonsei Med J (2013) 1.03
Prostate-specific antigen levels among Chinese, Malays and Indians in Singapore from a community-based study. Asian Pac J Cancer Prev (2007) 0.92
Factors associated with continuing medical therapy after transurethral resection of prostate. Urology (2014) 2.74
Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy. Urology (2014) 2.05
Preoperative serum sex hormone-binding globulin as a predictive marker for extraprostatic extension of tumor in patients with clinically localized prostate cancer. Eur Urol (2008) 1.44
Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men? BJU Int (2010) 1.01
Primary immature teratoma of the prostate with angiosarcoma component: its unusual response to chemotherapy. Int J Urol (2006) 0.94
Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report. Radiat Oncol J (2013) 0.94
Salvage radiotherapy after radical prostatectomy: prediction of biochemical outcomes. PLoS One (2014) 0.93
Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract. Urol Int (2006) 0.88
Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma. BJU Int (2006) 0.87
Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract. Jpn J Clin Oncol (2007) 0.86
Influence of magnetic resonance imaging in the decision to preserve or resect neurovascular bundles at robotic assisted laparoscopic radical prostatectomy. J Urol (2014) 0.86
Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J Urol (2006) 0.85
Stratification of patients with intermediate-risk prostate cancer. BJU Int (2015) 0.85
De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery. Clin Genitourin Cancer (2016) 0.84
Comparison of perioperative outcomes of robotic versus laparoscopic partial nephrectomy for complex renal tumors (RENAL nephrometry score of 7 or higher). Korean J Urol (2014) 0.83
Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia. Urology (2008) 0.83
Preoperative glycemic control status as a significant predictor of biochemical recurrence in prostate cancer patients after radical prostatectomy. PLoS One (2015) 0.83
Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate. Korean J Urol (2015) 0.82
Optimal Skin-to-Stone Distance Is a Positive Predictor for Successful Outcomes in Upper Ureter Calculi following Extracorporeal Shock Wave Lithotripsy: A Bayesian Model Averaging Approach. PLoS One (2015) 0.82
Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean J Urol (2013) 0.82
Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer. World J Mens Health (2014) 0.80
Chronic lower urinary tract symptoms in young men without symptoms of chronic prostatitis: urodynamic analyses in 308 men aged 50 years or younger. Korean J Urol (2014) 0.80
A comparison of radiologic tumor volume and pathologic tumor volume in renal cell carcinoma (RCC). PLoS One (2015) 0.80
The nephrometry score: is it effective for predicting perioperative outcome during robot-assisted partial nephrectomy? Korean J Urol (2014) 0.80
Ureteral stenting can be a negative predictor for successful outcome following shock wave lithotripsy in patients with ureteral stones. Investig Clin Urol (2016) 0.79
Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy. Int J Urol (2015) 0.78
Clinical effect of abiraterone acetate in Korean patients with metastatic castration-resistant prostate cancer according to duration of androgen deprivation therapy. Korean J Urol (2015) 0.78
Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines. Investig Clin Urol (2016) 0.78
Comparison of robotic and open partial nephrectomy: Single-surgeon matched cohort study. Can Urol Assoc J (2014) 0.78
A comprehensive review of neuroanatomy of the prostate. Prostate Int (2013) 0.78
Rapid increase of health care utilization and cost due to benign prostatic hyperplasia in Korean men: retrospective population-based analysis using the Health Insurance Review and Assessment service data. J Korean Med Sci (2015) 0.78
Prognosis of prostate cancer with other primary malignancies. Korean J Urol (2014) 0.78
Can contemporary patients with biopsy Gleason score 3+4 be eligible for active surveillance? PLoS One (2014) 0.78
The use of exome genotyping to predict pathological Gleason score upgrade after radical prostatectomy in low-risk prostate cancer patients. PLoS One (2014) 0.77
Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection. J Korean Med Sci (2015) 0.77
Comparison of pathological and biochemical outcomes after radical prostatectomy in Korean patients with serum PSA ranges. J Korean Med Sci (2015) 0.77
Simple renal cyst and renal dysfunction: A pilot study using dimercaptosuccinic acid renal Scan. Nephrology (Carlton) (2016) 0.77
Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance. Prostate Int (2014) 0.76
High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after radiotherapy. Korean J Urol (2014) 0.76
Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients. Prostate Int (2015) 0.75
A comparative study on the efficacy of solifenacin succinate in patients with urinary frequency with or without urgency. PLoS One (2014) 0.75
A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients. Korean J Urol (2015) 0.75
KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway. PLoS One (2015) 0.75
Associations of Self-Reported Erectile Function with Non-Invasive Measurements of Endothelial Function: A Preliminary Study. World J Mens Health (2015) 0.75
Is intravesical Bacillus Calmette-Guérin therapy superior to chemotherapy for intermediate-risk non-muscle-invasive bladder cancer? An ongoing debate. J Korean Med Sci (2015) 0.75
A Case Report of Partial Nephrectomy of Mucinous Cystadenocarcinoma in Kidney and Its Literature Review. Cancer Res Treat (2015) 0.75
Location of positive surgical margin and its association with biochemical recurrence rate do not differ significantly in four different types of radical prostatectomy. Korean J Urol (2014) 0.75
Trends in the Use of Nephron-Sparing Surgery over 7 Years: An Analysis Using the R.E.N.A.L. Nephrometry Scoring System. PLoS One (2015) 0.75
Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma. J Korean Med Sci (2015) 0.75
Comparison of High, Intermediate, and Low Frequency Shock Wave Lithotripsy for Urinary Tract Stone Disease: Systematic Review and Network Meta-Analysis. PLoS One (2016) 0.75
Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer? J Korean Med Sci (2015) 0.75
Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy. Asian J Androl (2015) 0.75
Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy. Korean J Urol (2015) 0.75
Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer. Oncotarget (2016) 0.75
External Validation of Models for Prediction of Lymph Node Metastasis in Urothelial Carcinoma of the Bladder. PLoS One (2015) 0.75
Clinical value of core length in contemporary multicore prostate biopsy. PLoS One (2015) 0.75
Histologic variability and diverse oncologic outcomes of prostate sarcomas. Korean J Urol (2014) 0.75
A Systematic Review and Meta-Analysis of Functional Outcomes and Complications Following the Photoselective Vaporization of the Prostate and Monopolar Transurethral Resection of the Prostate. World J Mens Health (2016) 0.75
The type of nephrectomy has little effect on overall survival or cardiac events in patients of 70 years and older with localized clinical t1 stage renal masses. Korean J Urol (2014) 0.75
Comparison of the Width of Peritumoral Surgical Margin in Open and Robotic Partial Nephrectomy: A Propensity Score Matched Analysis. PLoS One (2016) 0.75
Laparoendoscopic single-site simple nephrectomy using a magnetic anchoring system in a porcine model. Investig Clin Urol (2016) 0.75
Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Korean J Urol (2015) 0.75
Association between Seminal Vesicle Invasion and Prostate Cancer Detection Location after Transrectal Systemic Biopsy among Men Who Underwent Radical Prostatectomy. PLoS One (2016) 0.75
Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer. Korean J Urol (2015) 0.75
Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy. Korean J Urol (2015) 0.75
Interval from prostate biopsy to radical prostatectomy does not affect immediate operative outcomes for open or minimally invasive approach. J Korean Med Sci (2014) 0.75
Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia. Korean J Urol (2015) 0.75
Simple Modification of the Bladder Outlet Obstruction Index for Better Prediction of Endoscopically-Proven Prostatic Obstruction: A Preliminary Study. PLoS One (2015) 0.75
Altered gene expression profile after exposure to transforming growth factor β1 in the 253J human bladder cancer cell line. Korean J Urol (2014) 0.75
Is lymphovascular invasion a powerful predictor for biochemical recurrence in pT3 N0 prostate cancer? Results from the K-CaP database. Sci Rep (2016) 0.75
Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion. J Clin Pathol (2015) 0.75
Favorable Gleason 3 + 4 Prostate Cancer Shows Comparable Outcomes With Gleason 3 + 3 Prostate Cancer: Implications for the Expansion of Selection Criteria for Active Surveillance. Clin Genitourin Cancer (2017) 0.75
Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses. Cancer Res Treat (2017) 0.75
Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea. J Cancer Res Ther (2014) 0.75
Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach. J Cancer Res Clin Oncol (2015) 0.75
Prognostic Significance of the Disparity Between Biopsy and Pathologic Gleason Score After Radical Prostatectomy in Clinical Candidates for Active Surveillance According to the Royal Marsden Criteria. Clin Genitourin Cancer (2016) 0.75
Induction of immunoglobulin transcription factor 2 and resistance to MEK inhibitor in melanoma cells. Oncotarget (2017) 0.75
Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy. Int Braz J Urol (2014) 0.75
Re-Stratification of Patients with High-Risk Prostate Cancer According to the NCCN Guidelines Among Patients Who Underwent Radical Prostatectomy: An Analysis Based on the K-CaP Registry. Cancer Res Treat (2017) 0.75
Comparison of preoperative adaptive enlargement of the contralateral normal kidney in patients nephrectomized for benign non-functioning kidney versus renal cell carcinoma. Int J Urol (2016) 0.75
Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy. Urol Oncol (2017) 0.75
Prognostic Value of Focal Positive Surgical Margins After Radical Prostatectomy. Clin Genitourin Cancer (2015) 0.75
Prostate International, an international academic forum on prostate diseases. Prostate Int (2013) 0.75
Selection Criteria for Active Surveillance of Patients with Prostate Cancer in Korea: A Multicenter Analysis of Pathology after Radical Prostatectomy. Cancer Res Treat (2017) 0.75
Metastatectomy prior to immunochemotherapy for metastatic renal cell carcinoma. Urol Int (2006) 0.75
Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy. Int J Urol (2015) 0.75
Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy. Jpn J Clin Oncol (2016) 0.75
Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma. PLoS One (2017) 0.75
Comparison of Oncologic Outcomes and Complications According to Surgical Approach to Radical Prostatectomy: Special Focus on the Perineal Approach. Clin Genitourin Cancer (2017) 0.75
Impact of prostatic apical shape and protrusion on early recovery of continence after robot-assisted radical prostatectomy. Urology (2014) 0.75